Stelo Glucose Biosensor System
FDA 510(k) K234070 · Dexcom, Inc.
Submission
- Device name
- Stelo Glucose Biosensor System
- Applicant
- Dexcom, Inc.
San Diego, CA, US - Received
- December 22, 2023
- Decision date
- March 5, 2024
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- SAF – Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.1355
- Specialty
- Clinical Chemistry
An integrated continuous glucose monitoring system (iCGM) for non-intensive glucose monitoring is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time to detect euglycemic and dysglycemic glucose levels in persons who are not on insulin and do not have a significant risk of problematic hypoglycemia. iCGM systems for non-intensive…
Other 510(k)s with product code SAF
More from Abbott
| 510(k) | Device | Decision |
|---|---|---|
| K262472 | Stelo Glucose Biosensor SystemSBH · Special | 08/11/2026SE |
| K260935 | Stelo Glucose Biosensor SystemSBH · Traditional | 06/12/2026SE |
| K261402 | Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose…QBJ · Traditional | 06/08/2026SE |
| K261359 | Stelo Glucose Biosensor SystemSAF · Special | 05/21/2026SE |
| K253737 | Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous…QBJ · Traditional | 02/03/2026SE |
| K253710 | Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous…QBJ · Special | 12/17/2025SE |
| K252818 | Dexcom Smart BasalQRX · Traditional | 11/18/2025SE |
| K243214 | Dexcom G7 15 Day Continuous Glucose Monitoring SystemQBJ · Traditional | 04/09/2025SE |
| K240902 | Dexcom G7 Continuous Glucose Monitoring SystemQBJ · Special | 04/23/2024SE |
| K234133 | Dexcom G7 Continuous Glucose Monitoring SystemQBJ · Traditional | 02/26/2024SE |
Questions and answers
When was Stelo Glucose Biosensor System cleared by the FDA?
Stelo Glucose Biosensor System (K234070) received a 510(k) decision of Substantially Equivalent on March 5, 2024, 74 days after the submission was received.
What is the product code of K234070?
The FDA product code is SAF – Integrated Continuous Glucose Monitor For Non-Intensive Glucose Monitoring, Over-The-Counter, a Class II (moderate risk) device regulated under 21 CFR 862.1355.